Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mia Wadelius

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Cardiovascular Therapeutics|April 11, 2016
Influence of APOE Gene Polymorphism on Interindividual and Interethnic Warfarin Dosage Requirement: A Systematic Review and Meta-AnalysisWan-Ying Yu, Xue Sun, Mia Wadelius, et al.
Pharmacogenomics|September 7, 2022
Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexateMarco Cavalli, Niclas Eriksson, Johanna Karlsson Sundbaum, et al.
Journal of Psychopharmacology (Oxford, England)|January 30, 2007
Placental transfer of quetiapine in relation to P-glycoprotein activityMelissa Rahi, Tuija Heikkinen, Sebastian Härtter, et al.
Pharmacogenomics|September 15, 2021
Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexateJohanna Karlsson Sundbaum, Eva Baecklund, Niclas Eriksson, et al.
Human Genetics|October 19, 2006
Association of warfarin dose with genes involved in its action and metabolismMia Wadelius, Leslie Y Chen, Niclas Eriksson, et al.
Expert Opinion on Drug Safety|August 20, 2014
Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patientsKaarina Kowalec, Elaine Kingwell, Eric M Yoshida, et al.
Genome Medicine|November 28, 2017
Cohort-specific imputation of gene expression improves prediction of warfarin dose for African AmericansAssaf Gottlieb, Roxana Daneshjou, Marianne DeGorter, et al.
European Journal of Clinical Pharmacology|January 12, 2013
Warfarin dose prediction in children using pharmacometric bridging--comparison with published pharmacogenetic dosing algorithmsAnna-Karin Hamberg, Lena E Friberg, Katarina Hanséus, et al.
International Journal of Otolaryngology|March 14, 2017
Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced AngioedemaEva Rye Rasmussen, Christian von Buchwald, Mia Wadelius, et al.
Frontiers in Genetics|October 3, 2022
Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic eventsSofia Attelind, Pär Hallberg, Mia Wadelius, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Cardiovascular Therapeutics|April 11, 2016
Influence of APOE Gene Polymorphism on Interindividual and Interethnic Warfarin Dosage Requirement: A Systematic Review and Meta-AnalysisWan-Ying Yu, Xue Sun, Mia Wadelius, et al.
Pharmacogenomics|September 7, 2022
Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexateMarco Cavalli, Niclas Eriksson, Johanna Karlsson Sundbaum, et al.
Journal of Psychopharmacology (Oxford, England)|January 30, 2007
Placental transfer of quetiapine in relation to P-glycoprotein activityMelissa Rahi, Tuija Heikkinen, Sebastian Härtter, et al.
Pharmacogenomics|September 15, 2021
Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexateJohanna Karlsson Sundbaum, Eva Baecklund, Niclas Eriksson, et al.
Human Genetics|October 19, 2006
Association of warfarin dose with genes involved in its action and metabolismMia Wadelius, Leslie Y Chen, Niclas Eriksson, et al.
Expert Opinion on Drug Safety|August 20, 2014
Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patientsKaarina Kowalec, Elaine Kingwell, Eric M Yoshida, et al.
Genome Medicine|November 28, 2017
Cohort-specific imputation of gene expression improves prediction of warfarin dose for African AmericansAssaf Gottlieb, Roxana Daneshjou, Marianne DeGorter, et al.
European Journal of Clinical Pharmacology|January 12, 2013
Warfarin dose prediction in children using pharmacometric bridging--comparison with published pharmacogenetic dosing algorithmsAnna-Karin Hamberg, Lena E Friberg, Katarina Hanséus, et al.
International Journal of Otolaryngology|March 14, 2017
Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced AngioedemaEva Rye Rasmussen, Christian von Buchwald, Mia Wadelius, et al.
Frontiers in Genetics|October 3, 2022
Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic eventsSofia Attelind, Pär Hallberg, Mia Wadelius, et al.
Pageof 10